The Role of Mismatch Repair Deficiency (MMR) in Endometrial Carcinoma Subtyping: A Pathologic Review

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 36

فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JAMPBR-2-3_004

تاریخ نمایه سازی: 20 آبان 1405

چکیده مقاله:

Assessing Mismatch Repair MMR status via immunohistochemical loss of MLH۱ and PMS۲ proteins is paramount in endometrial carcinoma EC. This deficiency, indicative of a hypermutable phenotype, serves as a critical prognostic factor and, more significantly, a strong predictive biomarker for therapeutic response, particularly guiding the successful application of immune checkpoint blockade therapies in patients with advanced or recurrent disease. This narrative review synthesized literature on MMR deficiency in Endometrial Carcinoma using systematic searches (PubMed, Scopus, etc.) up to January ۲۰۲۶. Key terms focused on MMR status, molecular subtyping, and immunotherapy in EC. Inclusion required peer-reviewed studies addressing pathological assessment or molecular classification with direct clinical correlation, ensuring a robust foundation for synthesis. MMR deficiency dictates the therapeutic strategy in Endometrial Carcinoma due to the resulting high Tumor Mutational Burden, which generates abundant neoantigens and creates “hot” tumors. This genomic instability confers exquisite sensitivity to Immune Checkpoint Inhibitors (ICBs), leading to tumor-agnostic FDA approval for anti-PD-۱ therapy in MSI-H cancers. Therefore, MMR status functions primarily as a predictive biomarker, guiding access to highly effective immunotherapy, especially in advanced or recurrent disease settings, superseding its complex prognostic implications.

نویسندگان

Ali Akbar Shekarchi

Associate Professor of Pathology, Department of Pathology, School of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • References[۱] Siegel RL, Miller KD, Jemal A. Cancer Statistics, ۲۰۱۷. ...
  • Cancer Genome Atlas Research Network; Kandoth C, Schultz N, et ...
  • Church DN, Stelloo E, Nout RA, et al. Prognostic significance ...
  • Bell DW, Ellenson LH. Molecular genetics of endometrial carcinoma. Annu ...
  • Nojadeh JN, Behrouz Sharif S, Sakhinia E. Microsatellite instability in ...
  • Buchanan DD, Tan YY, Walsh MD, et al. Tumor mismatch ...
  • Stelloo E, Nout RA, Osse EM, et al. Improved risk ...
  • An HJ, Kim KI, Kim JY, et al. Microsatellite instability ...
  • Auguste A, Genestie C, De Bruyn M, et al. Refinement ...
  • Basil JB, Good fellow PJ, Rader JS, Mutch DG, Herzog ...
  • Broaddus RR, Lynch HT, Chen LM, et al. Pathologic features ...
  • Cohn DE, Mutch DG, Herzog TJ, et al. Genotypic and ...
  • de Jong RA, Boerma A, Boezen HM, Mourits MJ, Hollema ...
  • Hirai Y, Banno K, Suzuki M, et al. Molecular epidemiological ...
  • Huang HN, Lin MC, Tseng LH, et al. Ovarian and ...
  • Black D, Soslow RA, Levine DA, et al. Clinic pathologic ...
  • Nagle CM, O'Mara TA, Tan Y, et al. Endometrial cancer ...
  • Kommoss S, McConechy MK, Kommoss F, et al. Final validation ...
  • Mackay HJ, Gallinger S, Tsao MS, et al. Prognostic value ...
  • Maruyama A, Miyamoto S, Saito T, Kondo H, Baba H, ...
  • Mills AM, Liou S, Ford JM, Berek JS, Pai RK, ...
  • Djordjevic B, Barkoh BA, Luthra R, Broaddus RR. Relationship between ...
  • Okoye EI, Bruegl AS, Fellman B, Luthra R, Broaddus RR. ...
  • Ruiz I, Martin-Arruti M, Lopez-Lopez E, Garcia-Orad A. Lack of ...
  • Shikama A, Minaguchi T, Matsumoto K, et al. Clinic pathologic ...
  • Stelloo E, Bosse T, Nout RA, et al. Refining prognosis ...
  • Talhouk A, Hoang LN, McConechy MK, et al. Molecular classification ...
  • Talhouk A, McConechy MK, Leung S, et al. Confirmation of ...
  • Jumaah AS, Salim MM, Al-Haddad HS, McAllister KA, Yasseen AA. ...
  • Moher D, Shamseer L, Clarke M, et al. Preferred reporting ...
  • Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-۲: a ...
  • Moghadam,A. M. (۲۰۲۵). Effectiveness of Intraoperative Neuromonitoring in Preventing Neurological ...
  • Moghadam,A. M. (۲۰۲۵). Efficacy and Safety of Minimally Invasive Versus ...
  • Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects ...
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency ...
  • Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for ...
  • Ryan NA, Glaire MA, Blake D, Cabrera-Dandy M, Evans DG, ...
  • Moghadam,A. M. (۲۰۲۵). Effectiveness of Intraoperative Neuromonitoring in Preventing Neurological ...
  • Ryan NAJ, Blake D, Cabrera-Dandy M, Glaire MA, Evans DG, ...
  • Jerzak KJ, Duska L, MacKay HJ. Endocrine therapy in endometrial ...
  • Ashley CW, Da Cruz Paula A, Kumar R, et al. ...
  • Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch ...
  • Fujiyoshi K, Yamamoto G, Takenoya T, et al. Metastatic pattern ...
  • Fountzilas E, Kotoula V, Pentheroudakis G, et al. Prognostic implications ...
  • Copija A, Waniczek D, Witkos A, Walkiewicz K, Nowakowska-Zajdel E. ...
  • Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, ...
  • Boland CR, Koi M, Chang DK, Carethers JM. The biochemical ...
  • Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial ...
  • Buchanan DD, Rosty C, Clendening M, Spurdle AB, Win AK. ...
  • Moghadam,A. M. (۲۰۲۶). Diagnostic and Prognostic Value of Circulating microRNAs ...
  • Najdawi F, Crook A, et al. Lessons learnt from implementation ...
  • Stelloo E, Jansen AM, et al. Practical guidance for mismatch ...
  • نمایش کامل مراجع